Ellen Bernstein, Walter Brooks, and David Godolphin, the three founders of Equinox Group, have worked together for more than 20 years. Together, they have decades of experience consulting to the world’s major pharmaceutical and biotechnology companies. Using elements from decision analysis, microeconomics, statistics and probability theory, and market research, they have led the development of methods to estimate the market potential for a new drug based on its clinical performance.

Before forming Equinox Group in 1995, the principals were the senior management of Decision Resources’ life sciences practice.